Personalizing Preprocedural Sedation for Regional Anesthesia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

October 22, 2022

Primary Completion Date

May 24, 2024

Study Completion Date

May 24, 2024

Conditions
Catastrophizing Pain
Interventions
DRUG

Midazolam and Fentanyl

Prior to the start of the nerve block, patients in Arm 1 will receive titrated pharmacological sedation with IV midazolam with a goal of achieving moderate sedation. If pain is felt despite subcutaneous lidocaine, IV fentanyl may be administered with a goal of achieving moderate sedation with analgesia.

BEHAVIORAL

Educational Reassurance

Patients in the nonpharmacologic group will receive intraprocedural education and reassurance without pharmacologic sedation. They will have the option to receive more pharmacologic sedation at any point during the nerve block (cross-over to titrated sedation group).

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER